# LYVISPAH
> **NDA215422** · New Drug Application · Sponsor: STRIDES PHARMA INTL · Approved 2021-11-22
## Drug
- **FDA Application Number:** NDA215422
- **Application type:** New Drug Application
- **Brand name:** LYVISPAH
- **Generic name:** BACLOFEN
- **Active ingredients:** BACLOFEN
- **Dosage form:** GRANULE
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** STRIDES PHARMA INTL
- **Manufacturer:** Amneal Pharmaceuticals LLC
- **First approval:** 2021-11-22
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215422)
---
*MORVS · CC0 1.0*